Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-09-11-Speech-2-381-003"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20120911.32.2-381-003"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"The amendment of the regulation on pharmacovigilance concerns loopholes that emerged after the outbreak of the scandal of the Mediator case in France. Although amendments to the regulation were adopted as recently as 2010, this case exposed weaknesses in those very changes. For these reasons, and as a way of making vigilance of medicines on the market more effective, the EU has proposed a range of standards obliging the agents involved to automatically divulge possible dangers to the corresponding entities. Once again, I am in favour of improving European legislation aimed at safeguarding the public."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples